QSS
CALA

Quantitative Systematic Strategies’s Calithera Biosciences, Inc CALA Stock Holding History

Quantitative Systematic Strategies’s Portfolio CALA Stock Details CALA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-764
Closed -$80K – 906
2018
Q3 		$80K Buy
+764
New +$72.8K 0.02% 584

Other funds holding CALA

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Man Group
Man Group London, United Kingdom $55.1B AUM 24.23% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Quantitative Systematic Strategies's CALA Position: Q4 2018 in Review

Quantitative Systematic Strategies sold out of Calithera Biosciences, Inc (CALA) in Q4 2018, closing a stake of 764 shares — an estimated $80K sold.

Quantitative Systematic Strategies first reported a position in CALA in Q3 2018 and held it in 1 quarter. The position peaked at $80K in Q3 2018. 77 funds tracked by Wall St. Rank hold CALA as of Q4 2018.

  • Quantitative Systematic Strategies reported no remaining Calithera Biosciences, Inc position as of Q4 2018 after selling out during the quarter.
  • Quantitative Systematic Strategies sold 764 Calithera Biosciences, Inc shares in Q4 2018, an estimated $80K.
  • Quantitative Systematic Strategies first reported a position in Calithera Biosciences, Inc in Q3 2018 and held it in 1 quarter.
  • Quantitative Systematic Strategies's Calithera Biosciences, Inc position peaked at $80K in Q3 2018.
  • 77 funds tracked by Wall St. Rank held Calithera Biosciences, Inc as of Q4 2018.

Based on Quantitative Systematic Strategies's 13F filing for Q4 2018, filed 12 Feb 2019.